2024 |
Tango Therapeutics Inc
|
Chairman of the Board |
318.4 K |
- |
2024 |
Revolution Medicines Inc
|
Lead Independent Director |
- |
- |
2024 |
Relay Therapeutics Inc
|
Chairperson of the Board |
- |
- |
2024 |
Blueprint Medicines Corp
|
Director |
- |
- |
2024 |
Opko Health Inc
|
Independent Director |
- |
- |
2023 |
Revolution Medicines Inc
|
Lead Independent Director |
510.6 K |
40.0 % |
2023 |
Blueprint Medicines Corp
|
Director |
397.3 K |
22.8 % |
2023 |
Opko Health Inc
|
Independent Director |
66.3 K |
-32.3 % |
2023 |
Relay Therapeutics Inc
|
Chairman of the Board |
- |
- |
2022 |
Relay Therapeutics Inc
|
Chairman of the Board |
573.6 K |
33.5 % |
2022 |
Revolution Medicines Inc
|
Lead Independent Director |
364.8 K |
-20.6 % |
2022 |
Blueprint Medicines Corp
|
Director |
323.5 K |
-27.1 % |
2022 |
Tango Therapeutics Inc
|
Chairman of the Board |
239.3 K |
289.3 % |
2022 |
Opko Health Inc
|
Independent Director |
97.9 K |
- |
2021 |
Revolution Medicines Inc
|
Lead Independent Director |
459.4 K |
60.4 % |
2021 |
Blueprint Medicines Corp
|
Independent Director |
443.7 K |
11.0 % |
2021 |
Relay Therapeutics Inc
|
Chairman of the Board |
429.6 K |
672.3 % |
2021 |
Tango Therapeutics Inc
|
Chairman of the Board |
61.5 K |
- |
2021 |
Opko Health Inc
|
Independent Director |
- |
- |
2020 |
Blueprint Medicines Corp
|
Independent Director |
399.6 K |
-9.3 % |
2020 |
Revolution Medicines Inc
|
Lead Independent Director |
286.4 K |
-16.6 % |
2020 |
Relay Therapeutics Inc
|
Independent Director |
55.6 K |
-64.9 % |
2020 |
Tango Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Blueprint Medicines Corp
|
Independent Director |
440.6 K |
19.6 % |
2019 |
Revolution Medicines Inc
|
Independent Director |
343.4 K |
- |
2019 |
Relay Therapeutics Inc
|
Independent Director |
158.6 K |
- |
2018 |
Blueprint Medicines Corp
|
Independent Director |
368.5 K |
1.7 % |
2018 |
Editas Medicine Inc
|
- |
9.2 K |
-94.9 % |
2018 |
Editas Medicine Inc
|
Independent Director |
- |
- |
2017 |
Blueprint Medicines Corp
|
Independent Director |
362.3 K |
105.8 % |
2017 |
Editas Medicine Inc
|
Independent Director |
179.1 K |
293.7 % |
2016 |
Blueprint Medicines Corp
|
Director |
176.0 K |
517.0 % |
2016 |
Editas Medicine Inc
|
Independent Director |
45.5 K |
- |
2015 |
Blueprint Medicines Corp
|
Director |
28.5 K |
- |
2015 |
Editas Medicine Inc
|
Director |
- |
- |
2014 |
Blueprint Medicines Corp
|
Director |
- |
- |